Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study

L Lorefice1, G Fenu1, E Carta2

  • 1Multiple Sclerosis Centre, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Italy.

Abstract

Insights

Bipolar disorder (BD) in multiple sclerosis (MS) patients is linked to reduced volumes in specific subcortical grey matter areas, including the putamen and nucleus accumbens. This suggests structural brain changes may underlie this common comorbidity.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Radiology

Background:

  • Bipolar disorder (BD) affects approximately 8% of multiple sclerosis (MS) patients.
  • Brain damage associated with BD comorbidity in MS remains unclear.
  • Subcortical grey matter (scGM) structures are crucial for affective functioning.

Purpose of the Study:

  • To investigate the association between brain atrophy, specifically in scGM structures, and the co-occurrence of BD in MS patients.
  • To determine if reduced scGM volumes correlate with the presence of BD in individuals with MS.

Main Methods:

  • Recruited MS patients with BD and a control group of MS patients without psychiatric disorders.
  • Utilized brain MRI to estimate whole brain (WB), white matter (WM), and grey matter (GM) volumes using SIENAX.
  • Estimated scGM volumes (putamen, caudate, thalamus, hippocampus, amygdala, nucleus accumbens, pallidus) using the FIRST tool.

Main Results:

  • No significant differences in WB, WM, or cortical GM volumes were found between MS patients with and without BD.
  • Multiple regression analysis revealed significantly lower volumes of the putamen and nucleus accumbens in MS patients with BD.
  • A trend towards significance was observed for reduced pallidus volume in MS patients with BD.

Conclusions:

  • Preliminary findings suggest that MS patients with BD exhibit smaller nucleus accumbens and putamen volumes.
  • Further research with larger cohorts is needed to confirm these findings and elucidate the underlying structural brain damage.
  • Understanding these structural changes is crucial for managing psychiatric comorbidities in MS.